151 related articles for article (PubMed ID: 35286235)
21. LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer.
Li X; Jiang S; Jiang T; Sun X; Guan Y; Fan S; Cheng Y
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296887
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA hsa_circ_0000117 accelerates the proliferation and invasion of gastric cancer cells by regulating the microRNA-337-3p/signal transducer and activator of transcription 3 axis.
Gao Q; Liu Q; Chen H
Bioengineered; 2021 Dec; 12(1):1381-1390. PubMed ID: 33896365
[TBL] [Abstract][Full Text] [Related]
23. Essential meiotic structure-specific endonuclease1 (
Guo Z; Liang E; Li W; Jiang L; Zhi F
Bioengineered; 2021 Dec; 12(2):9869-9884. PubMed ID: 34719326
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
25. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.
Fernandez-Mosquera L; Yambire KF; Couto R; Pereyra L; Pabis K; Ponsford AH; Diogo CV; Stagi M; Milosevic I; Raimundo N
Autophagy; 2019 Sep; 15(9):1572-1591. PubMed ID: 30917721
[TBL] [Abstract][Full Text] [Related]
27. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
[TBL] [Abstract][Full Text] [Related]
29. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract][Full Text] [Related]
30. CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer.
Zhou Z; Ma Z; Li Z; Zhuang H; Liu C; Gong Y; Huang S; Zhang C; Hou B
J Cancer; 2021; 12(19):5797-5806. PubMed ID: 34475993
[No Abstract] [Full Text] [Related]
31. sFRP3 and DKK1 Regulate Fibroblast-Like Synoviocytes Markers and Wnt Elements Expression Depending on Cellular Context.
Elhaj Mahmoud D; Sassi N; Drissi G; Barsaoui M; Zitouna K; Sahli H; Kallel-Sellami M; Kanoun L; Cheour E; Laadhar L
Immunol Invest; 2017 Apr; 46(3):314-328. PubMed ID: 28151034
[TBL] [Abstract][Full Text] [Related]
32. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.
Wei F; Ding L; Wei Z; Zhang Y; Li Y; Qinghua L; Ma Y; Guo L; Lv G; Liu Y
Oncotarget; 2016 Dec; 7(51):85259-85272. PubMed ID: 27845896
[TBL] [Abstract][Full Text] [Related]
33. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
[TBL] [Abstract][Full Text] [Related]
34. Chalepin: A Compound from
Richardson JSM; Aminudin N; Abd Malek SN
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
[TBL] [Abstract][Full Text] [Related]
35. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
36. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
[TBL] [Abstract][Full Text] [Related]
37. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
38. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
39. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.
Xu J; Zhang W
Cancer Cell Int; 2021 Oct; 21(1):521. PubMed ID: 34627255
[TBL] [Abstract][Full Text] [Related]
40. CircCCT3 Acts as a Sponge of miR-613 to Promote Tumor Growth of Pancreatic Cancer Through Regulating VEGFA/VEGFR2 Signaling.
Hou JP; Men XB; Yang LY; Han EK; Han CQ; Liu LB
Balkan Med J; 2021 Jul; 38(4):229-238. PubMed ID: 34274912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
